{"nct_id":"NCT05113251","title":"Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-10-25","start_date_type":"ACTUAL","primary_completion_date":"2025-03-12","primary_completion_date_type":"ACTUAL","completion_date":"2027-04-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}